The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Regulatory News (COA)

Share Price Information for Coats (COA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.90
Bid: 81.90
Ask: 82.30
Change: 1.40 (1.74%)
Spread: 0.40 (0.488%)
Open: 82.20
High: 82.50
Low: 80.50
Prev. Close: 80.50
COA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 May 2023 07:00

RNS Number : 6443Z
Coats Group PLC
17 May 2023
 

 

 

 17 May 2023

Coats Group plc

 

Trading update

Trading in line with full year expectations

 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread and global footwear component manufacturer, today announces a trading update for the period 1 January 2023 to 30 April 2023 ('the period').

 

· Market conditions and Group trading in the period were in line with our expectations

· Constant currency revenue decline of 7%, with organic CER revenues down 20%, against a very strong prior year comparator

· Operating profit margins were resilient, supported by strategic projects and tight cost control

· Full year expectations unchanged

 

1st January to 30th April 2023 vs same period in 2022

Reported

CER

Organic CER

Apparel

-27%

-22%

-22%

Footwear

58%

62%

-23%

Performance Materials

-16%

-13%

-13%

Total

-12%

-7%

-20%

 

All following references are on an CER basis unless specified.

 

The organic revenue decline of 20% in the period, against a very strong prior year comparator, reflects the continuation of the widespread industry destocking in Apparel and Footwear, together with previously disclosed customer contract in-sourcing in Performance Materials. This was in part offset by the annualised contribution from the prior year acquisitions in Footwear, with overall revenue declining by 7%.

As expected, Apparel revenues declined by 22% in the period reflecting a continuation of trends seen in Q4 2022, with destocking by customers adjusting to more subdued consumer demand and excess inventory levels.

 

Footwear revenue decreased by 23% organically, with similar destocking drivers to those seen in the Apparel markets. Reported divisional revenue increased by 58% year-on-year in the period, including the first time contribution from the acquisitions of Texon and Rhenoflex. The integration of both businesses is progressing to plan, with the realisation of synergy and efficiency benefits increasing, in line with expectations.

 

Revenue in Performance Materials reduced by 13% in the period. This was largely the result of the customer insourcing of a significant PPE contract in H2 2022.

 

Our strategic projects remain on-track and are delivering significant operational and financial benefits. These actions, alongside dynamic pricing, have supported operating margins at the beginning of 2023 and will continue to do so. Cash generation continues to be positive and a focus for the Group.

 

 

Outlook

 

With trading in the period in line with expectations we continue to anticipate full year 2023 performance consistent with the Board's expectations, with a second-half weighting, underpinned by the contribution from acquisitions, associated synergies and strategic projects.

 

With a significantly strengthened commercial and operational platform, the Group remains very well-positioned in its markets, as the global partner of choice for winning brands and with a clear leadership position in innovation and sustainability. Consequently, we remain excited about the growth and margin opportunities across the Group over the medium term, with improved cash generation providing an additional catalyst to our strategic ambitions.

 

The Group will release its interim results on 1 August 2023.

 

 

 

 

 

Enquiry details

 

 

 

Investors

Chris Dyett / Victoria Huxster

Coats Group plc

+44 (0)797 497 4690

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenue in 2022 was $1.6 billion. Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries. With a proud heritage dating back more than 250 years and spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a workforce of 17,000, serving its customers worldwide. Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are three dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to Science Based sustainability targets for 2030 and beyond, with an aspiration of achieving net-zero by 2050. Coats is also committed to achieving its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance. To find out more about Coats visit www.coats.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKABQCBKDPPD
Date   Source Headline
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement
11th Nov 202211:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.